Trending Stocks

Lucas GC Limited Announces 1H 2026 Financial Results: Revenue at US$35.74 million with Increases in Gross Margin

NEW YORK, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Lucas GC Limited (NASDAQ: LGCL) (“Lucas” or the “Company”), an artificial intelligence (the “AI”) technology-driven Platform-as-a-Service (the “PaaS”) company, applying such technologies in human r...

October 07, 2026 09:00:00 am | GlobeNewswire

AVBP Investors with $100,000 in Losses Have Opportunity to Join ArriVent BioPharma, Inc. Fraud Investigation with SBS Law

Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ArriVent BioPharma, Inc. (“ArriVent” or “the Company”) (NASDAQ: AVBP ) for violations of the...

October 07, 2026 10:56:00 pm | Business Wire

Valeura Energy Inc Announces Q3 2026 Operations Update

CALGARY, AB / ACCESS Newswire / October 7, 2026 / Valeura Energy Inc. (TSX:VLE)(OTCQX:VLERF) ("Valeura" or the "Company") provides an operations and financial update for Q3 2026. Highlights Oil production averaged 22.1 mbbls/d (1) ; Sales of 2.013 million bbls; Price realisations avera...

October 07, 2026 02:00:00 am | ACCESS Newswire

Roche Diagnostics delivers laboratory equipment to support Ebola testing in DRC

Roche Diagnostics delivers laboratory equipment to support Ebola testing in DRC PR Newswire Roche Diagnostics has provided two molecular testing instruments to Institut National de Santé Publique (INSP) to support Ebola testing capacity in the DRC. Roche will preconfigure the inst...

October 07, 2026 01:00:00 am | PR Newswire

Nurix Therapeutics Announces First Patient Enrolled in Phase 1b/2 Combination Study of Bexobrutideg in Chronic Lymphocytic Leukemia

First patient enrolled in cohort combining bexobrutideg with venetoclax Initial cohort to focus on relapsed/refractory CLL, with potential expansion to first-line CLL Strategy includes evaluation of bexobrutideg given in combination with venetoclax and selected antibodies in the Roche po...

October 07, 2026 01:00:00 am | GlobeNewswire

Stagwell Schedules Webcast to Discuss Financial Results for the Three and Nine Months Ended September 30, 2026

NEW YORK CITY, NY / ACCESS Newswire / October 8, 2026 / Stagwell (NASDAQ:STGW) , the global challenger network transforming marketing through AI, will report financial results for the three and nine months ended September 30, 2026, on Thursday, October 29, 2026, before mar...

October 08, 2026 09:00:00 am | ACCESS Newswire

Vir Biotechnology Announces PSMA-targeted PRO-XTEN® Dual-masked T-cell Engager VIR-5500 Received FDA Fast Track Designation for the Treatment of Prostate Cancer

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation to VIR-5500, a PSMA-targeted PRO-XTEN ® dual-masked T-cell engager (TCE), for the treatment of late-line metastatic castration-resistant prostate cancer (...

October 08, 2026 08:30:00 am | Business Wire

Danaher Accelerates Life Sciences Research with New AI-powered Autonomous Lab

Danaher Accelerates Life Sciences Research with New AI-powered Autonomous Lab PR Newswire Helping researchers to move from discovery to breakthrough up to 8x faster by combining AI, automation and innovation from across Danaher's ecosystem of industry-leading technologies WASHINGTON ...

October 07, 2026 07:00:00 am | PR Newswire